4-(1-Piperazinyl)-1H-pyrazolo[3,4-d]pyrimidine dihydrochloride, 95.0%, 250mg

Gadolinium oxide tablets 99.99% 10x6 mm for evaporation 100 g

2-Ethylphenol, 95.0%, 25g

Mono(2-acryloyloxyethyl) Succinate (stabilized with MEHQ)>90.0%(GC)25g

(R)-Oxetan-2-ylmethanamine, 98%, 10g

Di-n-octyl sulfoxide, 98%, 1g

8-Azabicyclo[3.2.1]-octane-8-carboxylic acid, 3-(hydroxymethyl)-, 1,1-dimethylethyl ester, (3-endo)-, 95.0%, 500mg

tert-butyl N-(5-oxooxolan-2-yl)carbamate, 95.0%, 250mg

2-Bromonicotinic acid, 97.0%, 1g

(1-(4-Bromo-3-methylphenyl)-3,5-dimethyl-1H-pyrazol-4-yl)methanol, 98%, 500mg

9-Chloro-5,6,7,8-tetrahydroacridine-3-carboxylic acid, 95.0%, 1g

5-benzyloxyindole-3-acetonitrile, 95.0%, 5g

5-[(4-methoxyphenyl)methoxy]-2-nitro-aniline, 97%, 10g